Ann Michelle Cunningham insider trades

Open-market stock purchases and sales by Ann Michelle Cunningham, Director at Vistagen Therapeutics, Inc, from SEC Form 4 filings since Jan 10, 2019.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • VTGN Vistagen Therapeutics, Inc: other filings, last Sep 9, 2025

Get free alerts when Ann Michelle Cunningham files a new trade →